Phase I/II trial of anti-PD-1 checkpoint inhibitor nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients with Extensive-Stage Small Cell Lung Cancer

Type of Cancer
Lung

Site
Hackensack

Sponsor
Georgetown

Protocol Number
CA209-9D6

To Learn More Call
(201)-510-0950